Celldex Therapeutics (CLDX) Shares Outstanding (Entity) (2010 - 2023)
Celldex Therapeutics (CLDX) Shares Outstanding (Entity) (2010 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 200.18 Mn |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 48,449.00 |
| Sep 30, 2023 | 47,261.00 |
| Jun 30, 2023 | 47,253.00 |
| Mar 31, 2023 | 47,214.00 |
| Dec 31, 2022 | 46,888.00 |
| Sep 30, 2022 | 47.10 Mn |
| Jun 30, 2022 | 46.76 Mn |
| Mar 31, 2022 | 46.75 Mn |
| Dec 31, 2021 | 42,870.00 |
| Sep 30, 2021 | 46.66 Mn |
| Jun 30, 2021 | 39.62 Mn |
| Mar 31, 2021 | 39.61 Mn |
| Dec 31, 2020 | 29,640.00 |
| Sep 30, 2020 | 39.56 Mn |
| Jun 30, 2020 | 22.08 Mn |
| Mar 31, 2020 | 17.73 Mn |
| Dec 31, 2019 | 16.97 Mn |
| Sep 30, 2019 | 15.90 Mn |
| Jun 30, 2019 | 14.82 Mn |
| Mar 31, 2019 | 12.84 Mn |